Clinical trials recruiting for Atherosclerotic Cardiovascular Disease (ASCVD)

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention
  NCT07581808 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
  NCT07743021 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 33 locations
• Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
  NCT06960902 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 9 locations
• The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
  NCT07315997 · Phase: Not specified · Ages: 35 Years to 79 Years · Sex: All (male and female) · 3 locations

Related conditions

Trials recruiting for Atherosclerotic Cardiovascular Disease (ASCVD) often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Atherosclerotic Cardiovascular Disease (ASCVD) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.